Kyle Bass' Coalition Gets Review Of Cholesterol Drug Patents
The Patent Trial and Appeal Board agreed Monday to review two more drug patents challenged by hedge fund manager Kyle Bass, finding his group had shown the patents, which are related...To view the full article, register now.
Already a subscriber? Click here to view full article